Acknowledging the varied expression of DSC2 across diverse cancer types and their respective subtypes, the significant association observed in this study between a low expression of DSC2 in EAC samples (relative to normal tissue) and an improved survival rate, positions DSC2 as a compelling candidate. Here, DSC2 is linked to cancer.